Intrinsic Value of S&P & Nasdaq Contact Us

Cencora, Inc. COR NYSE

NYSE • Healthcare • Medical - Distribution • US • USD

SharesGrow Score
53/100
2/7 Pass
SharesGrow Intrinsic Value
$386.89
+20.9%
Analyst Price Target
$408.00
+27.5%
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Cencora, Inc. (COR) trades at a trailing P/E of 38.6, forward P/E of 18.2. Trailing earnings yield is 2.59%, forward earnings yield 5.51%. PEG 6.78. Graham Number is $45.08.

Criteria proven by this page:

  • VALUE (32/100, Fail) — PEG > 2.0 means the stock is expensive even after accounting for growth (PEG 6.78).
  • Forward P/E 18.2 (down from trailing 38.6) — analysts expect earnings to grow, which would improve the valuation.
  • PEG Ratio 6.78 — above 2.0 suggests expensive relative to earnings growth.
  • Trailing Earnings Yield 2.59% — below bond yields — investors are paying a premium for expected growth rather than current earnings. Forward yield improves to 5.51% as earnings recover.
  • Analyst consensus target $408.00 (+27.5% upside) — significant upside potential according to Wall Street analysts.

Overall SharesGrow Score: 53/100 with 2/7 criteria passed.

SharesGrow 7-Criteria Score
53/100
SG Score
View full scorecard →
VALUE
32/100
Price-to-Earnings & upside
Proven by this page
FUTURE
79/100
Analyst consensus
→ Forecast
PAST
100/100
→ Income
HEALTH
33/100
Debt-to-Equity & liquidity
→ Health
~
MOAT
49/100
→ Income
~
GROWTH
48/100
→ Income
INCOME
30/100
→ Income

Valuation Snapshot — COR

Valuation Multiples
P/E (TTM)38.6
Forward P/E18.2
PEG Ratio6.78
Forward PEG0.15
P/B Ratio32.91
P/S Ratio0.19
EV/EBITDA18.1
Per Share Data
EPS (TTM)$8.37
Forward EPS (Est.)$17.62
Book Value / Share$10.79
Revenue / Share$1,677.37
FCF / Share$18.57
Yields & Fair Value
Earnings Yield2.59%
Forward Earnings Yield5.51%
Dividend Yield0.71%
Graham Number$45.08
SharesGrow IV$386.89 (+20.9%)
Analyst Target$408.00 (+27.5%)

Historical Valuation

Year P/E (TTM) PEG Ratio P/B Ratio P/S Ratio Dividend Yield
2016 12.0 -0.01 8.05 0.12 1.68%
2017 43.6 -0.58 8.75 0.12 1.77%
2018 12.2 0.03 6.89 0.12 1.65%
2019 20.2 -0.43 6.01 0.10 1.96%
2020 -5.8 0.01 -19.48 0.10 1.73%
2021 16.0 -0.11 110.13 0.11 1.49%
2022 16.6 1.85 -133.36 0.12 1.39%
2023 21.1 3.66 70.54 0.14 1.08%
2024 29.6 -2.50 69.17 0.15 0.93%
2025 39.0 7.05 40.17 0.19 0.72%

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year EPS (Diluted) Revenue Net Income Net Margin
2016 $1.79 $146.85B $58.71M 0%
2017 $2.20 $153.14B $74.86M 0%
2018 $2.22 $167.94B $77.92M 0%
2019 $4.04 $179.59B $855.37M 0.5%
2020 $-16.65 $189.89B $-3.41B -1.8%
2021 $7.39 $213.99B $1.54B 0.7%
2022 $8.04 $238.59B $1.7B 0.7%
2023 $8.53 $262.17B $1.75B 0.7%
2024 $7.53 $293.96B $1.51B 0.5%
2025 $7.96 $321.33B $1.55B 0.5%

Analyst Estimates

Year EPS (Avg) EPS Range Revenue (Avg) Revenue Range Analysts
2026 $17.63 $17.50 – $17.72 $345.8B $339.52B – $348.49B 8
2027 $19.57 $19.19 – $20.03 $369.22B $358.27B – $373.24B 8
2028 $21.70 $20.15 – $24.19 $395.04B $394.85B – $395.24B 4
2029 $24.52 $23.93 – $24.88 $434.52B $426.41B – $439.36B 1
2030 $27.61 $26.94 – $28.01 $481.62B $472.63B – $486.98B 1
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message